• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Wake Forest Baptist awarded $1.6 million to test iPad colon cancer screening app

Bioengineer by Bioengineer
July 1, 2019
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

WINSTON-SALEM, N.C. – July 1, 2019 – Doctors know that screening for colorectal cancer reduces mortality. However, more than one-third of age-eligible Americans go unscreened every year even though colon cancer remains the second leading cause of cancer death in the United States.

In an effort to increase colorectal screenings, doctors at Wake Forest Baptist Health developed a specially designed iPad application that allows patients to order a colon cancer screening test while waiting at the doctor’s office before a routine primary care visit.

Called mobile Patient Technology for Health-CRC (mPATH-CRC), the iPad app informs patients of their need for screening, helps them make a screening decision, lets them “self-order” a screening test and sends automated electronic messages to help them complete their chosen test.

Findings from a previous randomized trial of 450 patients published in the April 2018 edition of the journal Annals of Internal Medicine showed that use of the mPATH-CRC app doubled the proportion of patients who completed their colorectal screening.

Now thanks to a $1.6 million grant from the National Cancer Institute, mPATH-CRC will be tested in 28 primary care clinics in North Carolina and Kentucky.

“While hundreds of mobile health apps have been developed in recent years, the best strategies for incorporating apps in routine primary care remain unknown,” said the study’s principal investigator, David Miller, M.D., professor of internal medicine at Wake Forest Baptist Health.

“Patients often have down time while they are waiting for their doctor. Our mPATH-CRC app makes good use of that currently wasted time by empowering patients with the tools and information they need to get the colorectal cancer screening test that is right for them,” Miller said.

This five-year project is designed to determine the optimal way to implement mPATH-CRC and other technology-based programs in community-based primary care practices, increasing the use of life-saving screening tests and improving the delivery of medical care.

###

Media Contact
Marguerite Beck
[email protected]

Tags: cancerMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Low-Dose Radiation Shows Promise for Slowing Knee Osteoarthritis in Long-Term Trial

September 27, 2026

Gold Nanorods and Laser Light Strike at Cancer Stem Cells in Cats With Breast Tumors

September 27, 2026

Proton Beam Therapy Shows Durable Tumor Control in Rare Adult Brain Tumors

September 27, 2026

Radiation Oncology Takes Center Stage as Mayo Clinic Unveils Research at ASTRO 2026

September 26, 2026
Please login to join discussion

POPULAR NEWS

  • Trunk Control May Hold a Key to Balance and Fall Risk in Older Adults

    29 shares
    Share 12 Tweet 7
  • AI Tells Doctors When It Is Unsure About Cancer Treatment Success

    29 shares
    Share 12 Tweet 7
  • Engineered mini CRISPR enzyme gets a 60-fold power boost for gene editing

    29 shares
    Share 12 Tweet 7
  • When Autism Diagnoses Fade: Early Intervention and Milder Symptoms Mark Children Who Lose the Label

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Trunk Control May Hold a Key to Balance and Fall Risk in Older Adults

AI Tells Doctors When It Is Unsure About Cancer Treatment Success

Engineered mini CRISPR enzyme gets a 60-fold power boost for gene editing

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.